How Businesses Can Attack Cancer Costs

One of the strategies employers are using to sustain competitive, affordable health plans involves managing the cost of specialty biotech cancer drugs. Bruce Davis, principal and leader of Findley Davies Health and Group Benefits Practice, offers his perspective on this topic.

Columbus CEO Article